2. Participants in the included studies.
Study name | Intervention(s) and comparator(s) | Screened/eligible (N) | Randomized (N) | Analyzed (N): efficacy | Analyzed (N): safety | Finishing trial (N) |
Babjuk 2005 | Intervention: 1 g 5‐ALA + BL‐TURBT |
128/122 | 64 | 60 | NA | 60 |
Comparator: WL‐TURBT | 64 | 62 | NA | 62 | ||
Drăgoescu 2017 | Intervention: 0.85 g 5‐ALA + BL‐TURBT |
113/113 | 57 | 57 | NA | 57 |
Comparator: WL‐TURBT | 56 | 56 | NA | 56 | ||
Filbeck 2002 | Intervention: 1 g 5‐ALA + BL‐TURBT |
301/191 | 151 | 88 | NA | 88 |
Comparator: WL‐TURBT | 150 | 103 | NA | 103 | ||
Geavlete 2010 | Intervention: HAL + BL‐TURBT |
NA/446 | 223 | 176 | NA | NA |
Comparator: WL‐TURBT | 233 | 159 | NA | NA | ||
Geavlete 2012 | Intervention: HAL + BL‐TURBT |
362/269 | 181 | 125 | NA | 48 |
Comparator: WL‐TURBT | 181 | 114 | NA | 37 | ||
Gkritsios 2014 | Intervention: 0.85 g 5‐ALA + BL‐TURBT |
130/104 | 66 | 48 | NA | 48 |
Comparator: WL‐TURBT | 64 | 37 | NA | 37 | ||
Hermann 2011 | Intervention: 0.85 g 5‐ALA + BL‐TURBT |
223/223 | 115 | 68 | NA | 68 |
Comparator: WL‐TURBT | 118 | 77 | NA | 77 | ||
Karaolides 2012 | Intervention: HAL + BL‐TURBT |
102/102 | 49 | 41 | NA | 41 |
Comparator: WL‐TURBT | 53 | 45 | NA | 45 | ||
Kriegmaier 2002 | Intervention: 1 g 5‐ALA + BL‐TURBT |
165/129 | 83 | 65 | NA | 65 |
Comparator: WL‐TURBT | 82 | 64 | NA | 64 | ||
Neuzillet 2014 | Intervention: 0.85 g 5‐ALA + BL‐TURBT |
151/151 | 72 | 72 | NA | 43 |
Comparator: WL‐TURBT | 79 | 79 | NA | 50 | ||
O’Brien 2013 | Intervention: HAL + BL‐TURBT |
249/185 | 129 | 86 | NA | 63 |
Comparator: WL‐TURBT | 120 | 82 | NA | 67 | ||
Riedl 2001 | Intervention: 1 g 5‐ALA + BL‐TURBT |
115/102 | NA | 51 | 51 | NA |
Comparator: WL‐TURBT | NA | 51 | 51 | NA | ||
Rolevich 2017 | Intervention: 1 g 5‐ALA + BL‐TURBT |
525/377 | 252 | 174 | NA | NA |
Comparator: WL‐TURBT | 273 | 203 | NA | NA | ||
Schumacher 2010 | Intervention: 1 g 5‐ALA + BL‐TURBT |
300/279 | 153 | 141 | NA | 136 |
Comparator: WL‐TURBT | 147 | 138 | NA | 134 | ||
Stenzl 2010 | Intervention: 0.85 g 5‐ALA + BL‐TURBT |
814/766 | 382 | 200 | 421 | 200 |
Comparator: WL‐TURBT | 384 | 202 | 391 | 202 | ||
Stenzl 2011 | Intervention: 1 g 5‐ALA + BL‐TURBT |
381/370 | 192 | 183 | 187 | NA |
Comparator: WL‐TURBT | 189 | 176 | 183 | NA | ||
Intervention total | 2169 | 1635 | 659 | 994 | ||
Comparator total | 2183 | 1648 | 625 | 1011 | ||
Grand total | 4352 | 3283 | 1284 | 2005 |
5‐ALA: 5‐aminolevulinic acid
BL‐TURBT: blue light transurethral resection of bladder tumor
HAL: hexaminolevulinic acid
NA: not available
WL‐TURBT: white light transurethral resection of bladder tumor